Coronary heart disease:: At the interface of molecular genetics and preventive medicine
- 28 February 1999
- journal article
- review article
- Published by Elsevier BV in American Journal of Preventive Medicine
- Vol. 16 (2), 122-133
- https://doi.org/10.1016/s0749-3797(98)00138-x
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Influence of Diet and Nutritional Status on Drug MetabolismClinical Pharmacokinetics, 1996
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension.Hypertension, 1994
- Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotypeHuman Molecular Genetics, 1994
- Individual Variation in First-Pass MetabolismClinical Pharmacokinetics, 1993
- Molecular basis of human hypertension: Role of angiotensinogenCell, 1992
- Ethnic Differences in Drug Disposition and ResponsivenessClinical Pharmacokinetics, 1991
- The genetic polymorphism of debrisoquine/sparteine metabolism — Clinical aspectsPharmacology & Therapeutics, 1990
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.JCI Insight, 1990